ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,832.15
-2.49%
S&P 500
5,482.86
0.18%
Dow Jones
38,804.98
0.07%
US Dollar vs Yen
157.894
0.12%
Brent Oil
84.665
0.91%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Interpace Biosciences Inc (QX) (IDXG)

  7. Interpace Biosciences Inc (QX) (IDXG) ニュース

IDXG

Interpace Biosciences (QX) (IDXG)

Interpace Biosciences Inc (QX)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:IDXG
日付受信時刻ニュースソース見出しコード企業名
2024/05/1005 : 29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
2024/02/1307 : 01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:IDXGInterpace Biosciences Inc (QX)
2024/02/0620 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/12/1306 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/11/1706 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/11/0907 : 14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/11/0906 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IDXGInterpace Biosciences Inc (QX)
2023/10/2805 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/09/2305 : 53Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/09/2305 : 20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/08/1004 : 47Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/08/1002 : 27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IDXGInterpace Biosciences Inc (QX)
2023/08/0206 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:IDXGInterpace Biosciences Inc (QX)
2023/05/1305 : 35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2023/05/1305 : 24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
2023/05/0404 : 17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IDXGInterpace Biosciences Inc (QX)
2023/04/2905 : 20Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:IDXGInterpace Biosciences Inc (QX)
2023/03/2805 : 43Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2023/03/2805 : 40Edgar (US Regulatory)Annual Report (10-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/11/1507 : 28Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/11/1507 : 25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/11/0505 : 34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/10/0505 : 20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/09/2105 : 47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/09/2105 : 37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/09/1005 : 29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/09/0805 : 46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/08/1606 : 46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/05/1706 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
2022/05/1705 : 51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
 Showing the most relevant articles for your search:USOTC:IDXG

最近閲覧した銘柄

NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
AMEX
XLF
Financial Select Sector
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
CCOM
US30
US 30
AMEX
XLE
Energy Select Sector SPDR
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
CCOM
US100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有